No Data
No Data
SSY Group (02005.HK) received a 5.93 million shareholding increase from Sichuan Kelun Pharmaceutical.
According to the latest equity disclosure data from the Hong Kong Stock Exchange, on August 21, 2024, SSY Group (02005.HK) acquired an additional 5.93 million shares of Sichuan Kelun Pharmaceutical Co., Ltd. at an average price of HK$3.536 per share, with a total investment of approximately HK$20.9685 million. After the shareholding, the latest shareholding of Sichuan Kelun Pharmaceutical Co., Ltd. is 628,776,000 shares, and the shareholding ratio has increased from 20.98% to 21.18%.
Hong Kong stocks fluctuate | SSY Group (02005) fell more than 4%. The seventh batch of bids for hydrobromide hexyl bromide injection was canceled, and its subsidiary was included in the list of violations.
The stock price of ssy group (02005) fell more than 4%, as of the time of publication, it fell 4.21%, reaching HK$3.41, with a turnover of HK$5.3388 million.
SSY Group Addresses Tender Cancellation Impact
ssy group (02005): Shijiazhuang Siyao is considered to have violated relevant commitments and terms in the bidding for the seventh batch of national centralized procurement of bromohexane hydrochloride injection.
SSY Group (02005) announced that on August 21, 2024 (after the trading session), the company learned of a...
Express News | SSY Group - Only Very Small Portion of Group's Overall Sales Regarding Period of Six Months From 21 Aug to 20 Feb Would Be Affected
Express News | SSY Group - Was Aware of Public Statement Published by National Medicine Joint Procurement Office
No Data